RetractedArticleRSC advances2021
Retraction: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells.
Laura FisherPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.